RICHMOND HILL, ON, Sept. 17 /CNW/ - Ajanta Pharma has entered into an
in-licensing agreement with Prollenium Medical Technologies of Canada and will
have exclusive marketing rights for Prollenium's highly successful dermal
filler 'Revanesse(R)' in India.
Prollenium Technologies has vast experience in the medical aesthetic
industry and is involved in developing next generation products for the
aesthetic market. Announcing the tie-up, Yogesh Agrawal, executive director,
Ajanta Pharma Limited, said, "The launch of Revanesse(R) is of great
significance for Ajanta as we continue to build our strengths in the
"We are extremely pleased to align ourselves with an up and coming
powerhouse on the Indian pharmaceutical scene," commented Mr. Ario Khoshbin,
managing director of Prollenium Medical Technologies Inc. "Our newly cemented
relationship with Ajanta will increase our reach in Asia, further enhancing
our global presence," added Mr. Khoshbin.
The total dermatology market in India is valued at approximately
$330 million and lifestyle cosmeceutical products like 'dermal' fillers and
anti-aging products are fast gaining in popularity.
Ajanta Pharma, which is ranked by IMS-ORG as one of the fastest growing
pharmaceutical companies in India, has a well established portfolio in
dermatology, cardiology and ophthalmology. The launch of Revanesse(R) will
strengthen the company's portfolio in the aesthetic segment in India.
Prollenium Medical Technologies is one of the top 50 fastest growing
companies in Canada as ranked by Profit magazine. With a team of researchers
and directors with over 25 years of experience in the medical aesthetic
industry, the company has developed and is currently developing cutting edge
and time-tested products for the aesthetic market. They are dedicated to
designing, manufacturing and distributing a full range of aesthetic products,
implants and injectables for surgeons, physicians and other health care
For more information on Prollenium Medical Technologies or on the
Revanesse Family of Fillers, please visit <a href="http://www.prollenium.co">www.prollenium.com</a>
For further information:
For further information: Mr. Ario Khoshbin, T: (905) 508-4581, E: